The recent announcement of a reduction in force of thousands of employees at the Department of Health and Human Services (HHS) will have major impacts across the health care sector. This overhaul, which includes the dismissal and retirement of senior leaders, attorneys, and top scientists across the Department, has affected key agencies such as the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Centers for Medicare & Medicaid Services (CMS), the Health Resources and Services Administration (HRSA) and the Centers for Disease Control and Prevention (CDC).
Join this important and timely webinar featuring Foley Hoag partners Thomas Barker, Bryant Godfrey and Andrew London. This session addressed the recent layoffs within federal health agencies, a significant event that has reshaped the landscape of public health and regulatory oversight in the U.S.
Key Discussion Points:
- Impact on Public Health and Safety: Understanding the immediate and long-term effects of the layoffs on disease tracking, food safety and medical research.
- Regulatory Changes: How the restructuring of HHS and the creation of the Administration for a Healthy America will alter regulatory practices and oversight.
- Legal and Policy Implications: Analyzing the legal ramifications of the layoffs and the potential challenges that may arise.
- Future Directions: Exploring the strategies and measures that can be adopted to mitigate the impact of these changes and ensure continued protection of public health.
Who Should Attend:
- Public health professionals
- Regulatory affairs specialists
- Legal professionals in health law
- Policymakers and government officials
- Healthcare providers and administrators
- Researchers and academics in public health and medical fields
Download presentation materials here.
